26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Antibacterial resistance is an increasing treat in infectious disease treatment requiring the discovery of new compounds. Dehydrozingerone, a curcumin degradant has attracted investigations because of its pharmacological activities. In this study, 22 compounds were synthesized and screened on 6 bacteria: Staphylococcus aureus, Meticilin Resistant Staphylococcus aureus, Escherisia coli, Pseudomonas aeruginosa, Klebsiala pneumonia, Salmonela Tiphymurium. All compounds tested displayed activity on at last two bacteria.

Produktbeschreibung
Antibacterial resistance is an increasing treat in infectious disease treatment requiring the discovery of new compounds. Dehydrozingerone, a curcumin degradant has attracted investigations because of its pharmacological activities. In this study, 22 compounds were synthesized and screened on 6 bacteria: Staphylococcus aureus, Meticilin Resistant Staphylococcus aureus, Escherisia coli, Pseudomonas aeruginosa, Klebsiala pneumonia, Salmonela Tiphymurium. All compounds tested displayed activity on at last two bacteria.
Autorenporträt
El Dr. Blaise Dackouo es farmacéutico y profesor de investigación en la Facultad de Farmacia de la universidad pública de Bamako desde 2008. De 2009 a 2011, asistió a la Universidad de Lieja (Bélgica), donde obtuvo un máster en ciencias farmacéuticas.